CSI Market
Sign In | Register

Aurinia Pharmaceuticals Inc (AUPH) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access AUPH Annual Income Statement →
The data below summarizes Aurinia Pharmaceuticals Inc's income statement results from Mar 31 2025 to Mar 31 2026, enabling period-by-period comparison of operating performance.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
Q1 2026 		(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax77.71
Total Revenue77.71
Costs & Expenses
Cost of Goods and Services Sold6.51
Gross Profit71.20
Selling, Administration, Marketing22.03
Depreciation & Amortization0.20
Research and Development Expense7.47
Other Operating Expense / -Income1.29
Total operating costs including COS36.28
Operating income / -loss41.42
Net Interest Expense / -Income0.00
Investment Income, Interest3.52
Other loss / -income-2.50
Total costs & expenses36.28
Income & Taxes
Income / -loss before income taxes43.93
Income taxes expenses / -benefit9.28
Income after income taxes34.36
Net income / -loss of other equity0.00
Income / -loss from continuing operations34.36
Net income / -loss34.36
Income / -loss to shareholder34.36
EBIT43.93
EBITD48.74
EBITDA48.94
Earnings Per Share
Basic EPS (excl. extra items)0.26
Basic Net EPS0.26
Basic shares outstanding (Mill. of Units)132.38
Diluted Net EPS0.25
Diluted average shares (Mill. of Units)137.64
4 historic quarters locked

Sign in to unlock the full Aurinia Pharmaceuticals Inc income statement history.

Sign In Create Free Account

About Aurinia Pharmaceuticals Inc Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: August 6, 2026
  • Original filing: auph-20260630.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.